Siemens

Siemens has been awarded US Patent No. 8,352,195, "Methods and systems for identifying PCR primers specific to one or more target genomes."
Lance Palmer, Daniel Fasulo, Lujia Chen, and Gayle Wittenberg are named as inventors.

Siemens Healthcare Diagnostics this week introduced its new Innovance Free Protein S Antigen assay for free protein S antigen testing.

NEW YORK (GenomeWeb News) – Affymetrix today said that it has expanded its license agreement with Siemens Healthcare Diagnostics for its branched DNA (bDNA) technology.

BG Medicine said last week that it filed a 510(k) submission with the US Food & Drug Administration for an automated version of its BGM Galectin-3 heart failure test to be run on Abbott Laboratories' Architect platform.

Integrated Diagnostics this week said it has launched a new operating division called InDi Imaging to commercialize PET imaging probes based on its protein catalyzed capture agent, or PCC, technology.

BG Medicine this week reported a 44 percent drop in first-quarter revenues year over year as its service revenues fell but its product revenues rose sharply.

Thermo Fisher Scientific said this week it has acquired the exclusive rights from diagnostics firm Nephromics to use placental growth factor protein as a biomarker for the diagnosis of preeclampsia and eclampsia.

AmberGen is developing a microbead-based, multiplexed, in vitro pediatric allergy test. The diagnostic is designed to enable the detection of multiple allergen-specific IgE antibodies in blood, according to a company executive.

By Tony Fong
NEW YORK (GenomeWeb News) – As companion diagnostics gain acceptance within the pharmaceutical sector and next-generation sequencing progresses toward clinical applications, Siemens is seeking a bigger role in the genomics space.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.